哈尔滨医科大学学报
哈爾濱醫科大學學報
합이빈의과대학학보
JOURNAL OF HARBIN MEDICAL UNIVERSITY
2014年
6期
439-443
,共5页
高瑞辰%查传琴%侯云龙%朱久新%吴艳萍%王文技%何健%乔国芬%吕延杰
高瑞辰%查傳琴%侯雲龍%硃久新%吳豔萍%王文技%何健%喬國芬%呂延傑
고서신%사전금%후운룡%주구신%오염평%왕문기%하건%교국분%려연걸
大明胶囊%1型糖尿病%β细胞%凋亡%链脲佐菌素
大明膠囊%1型糖尿病%β細胞%凋亡%鏈脲佐菌素
대명효낭%1형당뇨병%β세포%조망%련뇨좌균소
Daming capsule%type 1 diabetes%β-cells%apoptosis%streptozocin
目的研究大明胶囊(Daming capsule,DM)对链脲佐菌素(streptozocin,STZ)诱导的1型糖尿病大鼠的血糖影响。方法将65只成年雄性Sprague-Dawley(SD)大鼠随机分为5组:DM低(50 mg?kg-1? d-1)、中(100 mg? kg-1? d-1)、高(200 mg? kg-1? d-1)剂量组、空白组及模型组。灌胃给予大鼠不同浓度的DM,空白组和模型组给予同等体积的生理盐水,每天两次。两周后,腹腔注射STZ 65 mg? kg -1建立1型糖尿病模型。 STZ注射后3天、7天检测大鼠空腹血糖,1个月后检测糖耐量。苏木素-伊红( HE)染色和末端脱氧核糖核苷酸转移酶介导的缺口末端标记法( TUNEL)观察各组胰岛形态学和凋亡。结果 DM显著降低STZ诱导糖尿病大鼠的空腹血糖值并改善糖尿病大鼠的糖耐量;在STZ大鼠,HE染色显示DM升高STZ大鼠胰岛的数量;TUNEL染色结果显示DM组的胰岛β细胞凋亡较STZ模型组显著减少。结论预防性给予DM能降低STZ诱导的1型糖尿病大鼠空腹血糖并明显改善糖耐量,减少胰岛β细胞凋亡。
目的研究大明膠囊(Daming capsule,DM)對鏈脲佐菌素(streptozocin,STZ)誘導的1型糖尿病大鼠的血糖影響。方法將65隻成年雄性Sprague-Dawley(SD)大鼠隨機分為5組:DM低(50 mg?kg-1? d-1)、中(100 mg? kg-1? d-1)、高(200 mg? kg-1? d-1)劑量組、空白組及模型組。灌胃給予大鼠不同濃度的DM,空白組和模型組給予同等體積的生理鹽水,每天兩次。兩週後,腹腔註射STZ 65 mg? kg -1建立1型糖尿病模型。 STZ註射後3天、7天檢測大鼠空腹血糖,1箇月後檢測糖耐量。囌木素-伊紅( HE)染色和末耑脫氧覈糖覈苷痠轉移酶介導的缺口末耑標記法( TUNEL)觀察各組胰島形態學和凋亡。結果 DM顯著降低STZ誘導糖尿病大鼠的空腹血糖值併改善糖尿病大鼠的糖耐量;在STZ大鼠,HE染色顯示DM升高STZ大鼠胰島的數量;TUNEL染色結果顯示DM組的胰島β細胞凋亡較STZ模型組顯著減少。結論預防性給予DM能降低STZ誘導的1型糖尿病大鼠空腹血糖併明顯改善糖耐量,減少胰島β細胞凋亡。
목적연구대명효낭(Daming capsule,DM)대련뇨좌균소(streptozocin,STZ)유도적1형당뇨병대서적혈당영향。방법장65지성년웅성Sprague-Dawley(SD)대서수궤분위5조:DM저(50 mg?kg-1? d-1)、중(100 mg? kg-1? d-1)、고(200 mg? kg-1? d-1)제량조、공백조급모형조。관위급여대서불동농도적DM,공백조화모형조급여동등체적적생리염수,매천량차。량주후,복강주사STZ 65 mg? kg -1건립1형당뇨병모형。 STZ주사후3천、7천검측대서공복혈당,1개월후검측당내량。소목소-이홍( HE)염색화말단탈양핵당핵감산전이매개도적결구말단표기법( TUNEL)관찰각조이도형태학화조망。결과 DM현저강저STZ유도당뇨병대서적공복혈당치병개선당뇨병대서적당내량;재STZ대서,HE염색현시DM승고STZ대서이도적수량;TUNEL염색결과현시DM조적이도β세포조망교STZ모형조현저감소。결론예방성급여DM능강저STZ유도적1형당뇨병대서공복혈당병명현개선당내량,감소이도β세포조망。
Objective To study the protective effects of Daming capsule ( DM) in type 1 dia-betic rats.Methods Sixty-five male sprague-dawley (SD) rats were randomly divided into 5 groups (13 rats/group):low dose group (50 mg? kg -1? d -1 ), middle dose group (100 mg? kg -1? d-1 ) , high dose group of DM ( 200 mg? kg -1? d-1 ) , control group , and diabetes group .DM group received DM twice a day via gavage for two weeks;control group and diabe-tes group received equal volume of distilled water .Rats were administered with a single intra-peritoneal ( i.p.) injection of streptozocin ( STZ) 65 mg? kg -1 after two weeks of DM .The fasting blood glucose was measured on day 3 and 7 after STZ treatment and glucose tolerance test was performed on day 30 after STZ treatment.Hematoxylin and eosin stain (HE stain) and terminal-deoxynucleotidyl transferase mediated nick end labeling ( TUNEL ) assay were per-formed on the pancreas of the rats .Results Significant increase in the fasting blood glucose and abnormal glucose tolerance were found in the STZ-treated rats compared to controls ( P<0.05 ) .Rats treated with different doses of DM had significant decrease in the fast blood glu-cose ( P <0.05 ) and profound improvement in glucose tolerance in diabetic rats .HE stain showed that DM protected pancreatic islet against STZ damage , reflected by increase of number of pancreatic islets in diabetic rats ( P<0.05 ) .TUNEL results showed that DM attenuated ap-optosis of pancreatic β-cells compared with diabetes group .Conclusion DM decreases the fasting blood glucose level and improves glucose tolerance by at least protecting β-cells from ap-optosis in type 1 diabetic rats .